These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24337364)

  • 41. [Congenital nephrogenic diabetes insipidus: a difficult diagnosis?].
    van Lieburg AF; Knoers NV; Monnens LA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):609-12. PubMed ID: 9190534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of hydrochlorothiazide and amiloride in renal hypophosphatemic rickets.
    Alon U; Chan JC
    Pediatrics; 1985 Apr; 75(4):754-63. PubMed ID: 3885156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Congenital nephrogenic diabetes insipidus: about a case report].
    Esselmani H; Yassine A; Bouabdellah M; Benchekroun L; Handor N; Elalami S; Chabraoui L
    Ann Biol Clin (Paris); 2013; 71(2):241-5. PubMed ID: 23587596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bladder function impairment in aquaporin-2 defective nephrogenic diabetes insipidus.
    Shalev H; Romanovsky I; Knoers NV; Lupa S; Landau D
    Nephrol Dial Transplant; 2004 Mar; 19(3):608-13. PubMed ID: 14767016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.
    Knoers N; Monnens LA
    Pediatr Nephrol; 1992 Sep; 6(5):476-82. PubMed ID: 1457333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nephrogenic diabetes insipidus in children (Review).
    Duicu C; Pitea AM; Săsăran OM; Cozea I; Man L; Bănescu C
    Exp Ther Med; 2021 Jul; 22(1):746. PubMed ID: 34055061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus.
    Allen HM; Jackson RL; Winchester MD; Deck LV; Allon M
    Arch Intern Med; 1989 May; 149(5):1123-6. PubMed ID: 2719505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lithium-induced nephrogenic diabetes insipidus.
    Stone KA
    J Am Board Fam Pract; 1999; 12(1):43-7. PubMed ID: 10050642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
    García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G;
    Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydrochlorothiazide, amiloride and tolmetin in the treatment of diabetes insipidus of Brattleboro rats.
    Alon U; Wellons MD; Chan JC
    Med Biol; 1985; 63(3):117-22. PubMed ID: 4068772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel mutation in the AVPR2 gene (222delA) associated with X-linked nephrogenic diabetes insipidus in a boy with growth failure.
    Abaci A; Wood K; Demir K; Büyükgebiz A; Böber E; Kopp P
    Endocr Pract; 2010; 16(2):231-6. PubMed ID: 19703807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Karimi Z
    Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus.
    Monn E
    Acta Paediatr Scand; 1981 Jan; 70(1):39-42. PubMed ID: 6782828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O; Jacobsen BB
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma.
    Zaki M; Schöneberg T; Al Ajrawi T; Al Said AN; Sangkuhl K; Römpler H
    Nephrol Dial Transplant; 2006 Apr; 21(4):1082-6. PubMed ID: 16423865
    [No Abstract]   [Full Text] [Related]  

  • 59. Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis.
    Uwumugambi NA; Sanchorawala V; Shelton AC; Stern L; Gordon CE
    Am J Kidney Dis; 2017 Feb; 69(2):317-319. PubMed ID: 27780577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.
    Mizuno H; Sugiyama Y; Ohro Y; Imamine H; Kobayashi M; Sasaki S; Uchida S; Togari H
    Endocrine; 2004 Jun; 24(1):55-9. PubMed ID: 15249704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.